PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23886079-2	2013	In vitro enzyme activity was measured in the presence of eugenol, and it was found to inhibit pancreatic alpha-amylase (IC(50) = 62.53 microg/mL) and lipase (IC(50) = 72.34 microg/mL) as well as angiotensin converting enzyme (ACE) activity (IC50 = 130.67 microg/mL).	Eugenol	57-64	angiotensin I converting enzyme	Rattus norvegicus	195-224	
23886079-2	2013	In vitro enzyme activity was measured in the presence of eugenol, and it was found to inhibit pancreatic alpha-amylase (IC(50) = 62.53 microg/mL) and lipase (IC(50) = 72.34 microg/mL) as well as angiotensin converting enzyme (ACE) activity (IC50 = 130.67 microg/mL).	Eugenol	57-64	angiotensin I converting enzyme	Rattus norvegicus	226-229	
23886079-4	2013	Furthermore, eugenol similar to acarbose reduced serum glycosylated hemoglobin (HbA1c), lipase and ACE levels.	Eugenol	13-20	angiotensin I converting enzyme	Rattus norvegicus	99-102	
26391896-6	2016	However, the administration of eugenol induced a clear improvement in cardiac biomarkers injury, reduced inflammatory mediators proteins, increased heart activities of superoxide dismutase and glutathione peroxidase with reduce in thiobarbituric acid-reactive substances content and inhibition of ventricular remodeling process through inhibition of ACE activity.	Eugenol	31-38	angiotensin I converting enzyme	Rattus norvegicus	350-353